Crossmark

Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on risk of diabetic eye complications

Crossref DOI link: https://doi.org/10.1007/s00125-024-06300-7

Published Online: 2024-10-30

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tsai, Yi-Hsuan

OjiNjideka Hemphill, Nefertiti

Kurth, Tobias
License Information

Text and Data Mining valid from 2024-10-30

Version of Record valid from 2024-10-30
More Information

Article History

Received: 9 August 2024

Accepted: 15 August 2024

First Online: 30 October 2024

Authors’ relationships and activities

: TK has received research grants from the German Federal Joint Committee (G-BA). He has also received personal compensation from Eli Lilly & Company, Novartis, <i>BMJ</i> and <i>Frontiers</i>. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.

: All authors drafted the article and reviewed it critically for important intellectual content. All authors approved the version to be published.

Document is current

Any future updates will be listed below